Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism β-lactamase inhibitors(Beta Lactamase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC9H10F3NO6S2 |
InChIKeyAQTJCCLHJHUHLE-UHFFFAOYSA-N |
CAS Registry107740-90-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Tuberculosis | Preclinical | US | 01 Jan 1987 | |
Tuberculosis | Preclinical | US | 01 Jan 1987 |